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Cancer growth and metastasis are strictly dependent on tumor angiogenesis, which is 
promoted by tumour cells upon secretion of a number of growth factors. Vessel formation 
is a complex multistep process during which 'activated' endothelial cells (ECs), the first 
mechanical and functional interface between blood and tissues, proliferate, migrate, 
differentiate and are stabilized in a new circulatory network. Being involved in nearly all of 
the ‘hallmarks of cancer’, there is an increasing consensus on the idea that ion channels 
play a significant role in driving cancer progression at all stages. Accumulating evidence 
tends to demonstrate that the development of some cancers could also involve such ion 
channel aberrations. In this context ion channels may be seen as potential novel therapeutic, 
diagnostic, and prognostic targets for anti-cancer therapies. The discovery of Transient 
Receptor Potential (TRP) superfamily of channels provided putative candidates for non-
voltage-gated Ca2+ entry mechanisms. Notably, several TRP proteins are up regulated in 
cancer cells and have been suggested as valuable markers in predicting cancer progress and 
as potential targets for pharmaceutical therapy. In particular, the cold/menthol-sensitive 
TRPM8 (belonging to the ‘melastatin’ TRP subfamily) has emerged as an important factor 
in cell migration and prostate cancer (PCa) progression
1
. TRPM8 channel activation by 
menthol could be used to induce apoptosis of TRPM8-expressing prostate cancer cells and 
to inhibit angiogenesis. A great advancement in anti-angiogenic therapy has come from the 
use of nanotechnology since several nanovectors have been used as drug delivery systems 
(DDS) to efficiently target and kill tumor-associated vasculature. In this project we pursue a 
strategy  of drug delivery using  Halloysite nanotubes (HNTs) functionalized to target 
tumor angiogenesis in PCa, conjugating these nanomaterials with a selective TRPM8 
activator such as menthol. We evaluated the cytotoxic effect of functionalized HNTs on 
Human Endothelial Microvascular Cells (HMECs) trough cellular toxicity in vitro assay. 
HNTs were then functionalized with fluoresceine isotiocyanate (FITC) to study their 
cellular localization and finally we decided to non-covalently functionalize HNTs with 
menthol through vacuum cycles to selectively activate TRPM8 in HMECs.
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 Consequently, 
menthol-functionalized HNTs’ antiangiogenic role compared to free menthol was tested on 
HMEC through ECs migration and tubulogenesis in vitro assays.  Menthol release was 
studied by GC-MS and the functionalized nanomaterials were characterized by TGA, SEM 
and TEM. 
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